Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2024

Open Access 01-12-2024 | Confusion | Review

Psychotic illness in people with Prader–Willi syndrome: a systematic review of clinical presentation, course and phenomenology

Authors: Lucie C. S. Aman, Suzannah D. Lester, Anthony J. Holland, Paul C. Fletcher

Published in: Orphanet Journal of Rare Diseases | Issue 1/2024

Login to get access

Abstract

Background

Prader–Willi syndrome (PWS) is a rare and complex neurodevelopmental disorder resulting from absent paternal expression of maternally imprinted genes at chromosomal locus 15q11-13. This absence of expression occurs as a consequence of a deletion on the chromosome 15 of paternal origin (ca. 70%), a chromosome 15 maternal uniparental disomy (mUPD; ca. 25%), or an imprinting centre defect (IC; ca. 1–3%). At birth, individuals with PWS are severely hypotonic and fail to thrive. Hyperphagia and characteristic physical and neuropsychiatric phenotypes become apparent during childhood. The risk for the development of a co-morbid psychotic illness increases during the teenage years, specifically in those with PWS due to the presence of an mUPD. The primary aim of this literature review is to inform clinical practice. To achieve this, we have undertaken a systematic analysis of the clinical research literature on prevalence, presentation, course, characteristics, diagnosis and treatment of psychotic illness in people with PWS. The secondary aim is to identify clinical aspects of psychotic illness in PWS in need of further investigation.

Methods and findings

A systematic literature review on psychosis in PWS was conducted on the databases Web of Knowledge, PubMed and Scopus, using the terms “((Prader–Willi syndrome) OR (Prader Willi Syndrome)) AND ((psychosis) OR (psychotic illness))”. All articles written in English and reporting original human research were reviewed. In all but three of the 16 cohort studies in which the genetic types were known, the authors reported higher rates of psychosis in people with PWS resulting from an mUPD, compared to those with the deletion subtype of PWS. When psychosis was present the presentation was psychosis similar regardless of genetic type and was usually characterised by an acute onset of hallucinations and delusions accompanied by confusion, anxiety and motor symptoms.

Conclusions

The onset of confusion, an affective cyclical pattern with the presence of abnormal mental beliefs and experiences, usually of rapid onset is suggestive of the development of psychotic illness. Phenomenologically, this psychosis in people with PWS is atypical in comparison to schizophrenia and bipolar disorder in the general population. The relationship to psychosis in the general population and the optimum treatments remain uncertain.
Literature
1.
go back to reference Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet. 2001;38(11):792–8.PubMedPubMedCentralCrossRef Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet. 2001;38(11):792–8.PubMedPubMedCentralCrossRef
2.
go back to reference Aman LCS, Manning KE, Whittington JE, Holland AJ. Mechanistic insights into the genetics of affective psychosis from Prader–Willi syndrome. Lancet Psychiatry. 2018;5:370–8.PubMedCrossRef Aman LCS, Manning KE, Whittington JE, Holland AJ. Mechanistic insights into the genetics of affective psychosis from Prader–Willi syndrome. Lancet Psychiatry. 2018;5:370–8.PubMedCrossRef
3.
go back to reference Bellis SA, Kuhn I, Adams S, Mullarkey L, Holland A. The consequences of hyperphagia in people with Prader–Willi syndrome: a systematic review of studies of morbidity and mortality. Eur J Med Genet. 2022;65(1):104379.PubMedCrossRef Bellis SA, Kuhn I, Adams S, Mullarkey L, Holland A. The consequences of hyperphagia in people with Prader–Willi syndrome: a systematic review of studies of morbidity and mortality. Eur J Med Genet. 2022;65(1):104379.PubMedCrossRef
4.
go back to reference Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, et al. Prader–Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91:398–402.PubMedCrossRef Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, et al. Prader–Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91:398–402.PubMedCrossRef
5.
go back to reference Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader–Willi syndrome. Genet Med. 2012;14(1):10–26.PubMedCrossRef Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader–Willi syndrome. Genet Med. 2012;14(1):10–26.PubMedCrossRef
7.
go back to reference Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;2021:372. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;2021:372.
8.
go back to reference Prader A, Labhart AWH. A syndrome of obesity, hyposomia, cryptorchidism, and oligophrenia after a myotonic state in newborn. Swiss Weekly Med J. 1956;86:1260–1. Prader A, Labhart AWH. A syndrome of obesity, hyposomia, cryptorchidism, and oligophrenia after a myotonic state in newborn. Swiss Weekly Med J. 1956;86:1260–1.
9.
go back to reference Kollrack H, Wolff D. Paranoid-hallucinatory psychosis in the Prader–Labhart–Willi–Funconi-syndrom. Acta Paedopsychiatr. 1966;33(10):309–14.PubMed Kollrack H, Wolff D. Paranoid-hallucinatory psychosis in the Prader–Labhart–Willi–Funconi-syndrom. Acta Paedopsychiatr. 1966;33(10):309–14.PubMed
10.
go back to reference Clarke D, Webb T, Bachmannclarke J. Prader–Willi-syndrome and psychotic symptoms-report of a further case. Ir J Psychol Med. 1995;12(1):27–9.CrossRef Clarke D, Webb T, Bachmannclarke J. Prader–Willi-syndrome and psychotic symptoms-report of a further case. Ir J Psychol Med. 1995;12(1):27–9.CrossRef
12.
go back to reference Ewald H, Mors O, Flint T, Kruse TA. Linkage analysis between manic-depressive illness and the region on chromosome 15q involved in Prader–Willi syndrome, including two GABA(A) receptor subtype genes. Hum Hered. 1994;44(5):287–94.PubMedCrossRef Ewald H, Mors O, Flint T, Kruse TA. Linkage analysis between manic-depressive illness and the region on chromosome 15q involved in Prader–Willi syndrome, including two GABA(A) receptor subtype genes. Hum Hered. 1994;44(5):287–94.PubMedCrossRef
13.
go back to reference Whittaker JF, Cooper C, Harrington RC, Price DA. Prader–Willi syndrome and acute psychosis. Int J Psychiatry Clin Pract. 1997;1(3):217–9.PubMedCrossRef Whittaker JF, Cooper C, Harrington RC, Price DA. Prader–Willi syndrome and acute psychosis. Int J Psychiatry Clin Pract. 1997;1(3):217–9.PubMedCrossRef
14.
go back to reference Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE. The Prader–Willi syndrome: a study of 40 patients and a review of the literature. Medicine (United States). 1983;62:59–80. Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE. The Prader–Willi syndrome: a study of 40 patients and a review of the literature. Medicine (United States). 1983;62:59–80.
15.
go back to reference Whitman BY, Accardo P. Emotional symptoms in Prader–Willi syndrome adolescents. J Am Genet Med. 1987;28:897–905.CrossRef Whitman BY, Accardo P. Emotional symptoms in Prader–Willi syndrome adolescents. J Am Genet Med. 1987;28:897–905.CrossRef
16.
go back to reference Beardsmore A, Dorman T, Cooper SA, Webb T. Affective psychosis and Prader–Willi syndrome. J Intellect Disabil Res. 1998;42(Pt 6):463–71.PubMed Beardsmore A, Dorman T, Cooper SA, Webb T. Affective psychosis and Prader–Willi syndrome. J Intellect Disabil Res. 1998;42(Pt 6):463–71.PubMed
17.
go back to reference Clarke D. Prader–Willi syndrome and psychotic symptoms: 2. A preliminary study of prevalence using the psychopathology assessment schedule for adults with developmental disability checklist. J Intell Disabil Res. 1998;42(Pt 6):451–4. Clarke D. Prader–Willi syndrome and psychotic symptoms: 2. A preliminary study of prevalence using the psychopathology assessment schedule for adults with developmental disability checklist. J Intell Disabil Res. 1998;42(Pt 6):451–4.
18.
go back to reference Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D. Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet. 2002;359(9301):135–6.PubMedCrossRef Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D. Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet. 2002;359(9301):135–6.PubMedCrossRef
19.
go back to reference Vogels A, Matthijs G, Legius E, Devriendt K, Fryns J-P. Chromosome 15 maternal uniparental disomy and psychosis in Prader–Willi syndrome. J Med Genet. 2003;40(1):72–3.PubMedPubMedCentralCrossRef Vogels A, Matthijs G, Legius E, Devriendt K, Fryns J-P. Chromosome 15 maternal uniparental disomy and psychosis in Prader–Willi syndrome. J Med Genet. 2003;40(1):72–3.PubMedPubMedCentralCrossRef
20.
go back to reference Verhoeven WMA, Tuinier S, Curfs LMG. Prader–Willi syndrome: cycloid psychosis in a genetic subtype? Acta Neuropsychiatr. 2003a;15(1):32–7.PubMedCrossRef Verhoeven WMA, Tuinier S, Curfs LMG. Prader–Willi syndrome: cycloid psychosis in a genetic subtype? Acta Neuropsychiatr. 2003a;15(1):32–7.PubMedCrossRef
22.
go back to reference Louveau C, Turtuluci MC, Consoli A, Poitou C, Coupaye M, Krebs MO, et al. Prader–Willi syndrome: symptoms and topiramate response in light of genetics. Front Neurosci. 2023;17:6–11. Louveau C, Turtuluci MC, Consoli A, Poitou C, Coupaye M, Krebs MO, et al. Prader–Willi syndrome: symptoms and topiramate response in light of genetics. Front Neurosci. 2023;17:6–11.
23.
go back to reference Manzardo AM, Weisensel N, Ayala S, Hossain W, Butler MG. Prader–Willi syndrome genetic subtypes and clinical neuropsychiatric diagnoses in residential care adults. Clin Genet. 2018;93:622–31.PubMedPubMedCentralCrossRef Manzardo AM, Weisensel N, Ayala S, Hossain W, Butler MG. Prader–Willi syndrome genetic subtypes and clinical neuropsychiatric diagnoses in residential care adults. Clin Genet. 2018;93:622–31.PubMedPubMedCentralCrossRef
24.
go back to reference Pemmasani G, Yandrapalli S. Age-stratified prevalence of relevant comorbidities and etiologies for hospitalizations in Prader–Willi syndrome patients. Am J Med Genet A. 2021;185(2):600–1.PubMedCrossRef Pemmasani G, Yandrapalli S. Age-stratified prevalence of relevant comorbidities and etiologies for hospitalizations in Prader–Willi syndrome patients. Am J Med Genet A. 2021;185(2):600–1.PubMedCrossRef
25.
go back to reference Rice LJ, Agu J, Carter CS, Harris JC, Nazarloo HP, Naanai H, et al. The relationship between endogenous oxytocin and vasopressin levels and the Prader–Willi syndrome behaviour phenotype. Front Endocrinol (Lausanne). 2023;14:1–15.CrossRef Rice LJ, Agu J, Carter CS, Harris JC, Nazarloo HP, Naanai H, et al. The relationship between endogenous oxytocin and vasopressin levels and the Prader–Willi syndrome behaviour phenotype. Front Endocrinol (Lausanne). 2023;14:1–15.CrossRef
26.
go back to reference Rosenberg AGW, Wellink CM, Tellez Garcia JM, Pellikaan K, Van Abswoude DH, Davidse K, et al. Health problems in adults with Prader–Willi syndrome of different genetic subtypes: cohort study, meta-analysis and review of the literature. J Clin Med. 2022;11(14):4033.PubMedPubMedCentralCrossRef Rosenberg AGW, Wellink CM, Tellez Garcia JM, Pellikaan K, Van Abswoude DH, Davidse K, et al. Health problems in adults with Prader–Willi syndrome of different genetic subtypes: cohort study, meta-analysis and review of the literature. J Clin Med. 2022;11(14):4033.PubMedPubMedCentralCrossRef
27.
go back to reference Shriki-Tal L, Avrahamy H, Pollak Y, Gross-Tsur V, Genstil L, Hirsch HJ, et al. Psychiatric disorders in a cohort of individuals with Prader–Willi syndrome. Eur Psychiatry. 2017;44:47–52.PubMedCrossRef Shriki-Tal L, Avrahamy H, Pollak Y, Gross-Tsur V, Genstil L, Hirsch HJ, et al. Psychiatric disorders in a cohort of individuals with Prader–Willi syndrome. Eur Psychiatry. 2017;44:47–52.PubMedCrossRef
28.
go back to reference Soni S, Whittington J, Holland AJ, Webb T, Maina EN, Boer H, et al. The phenomenology and diagnosis of psychiatric illness in people with Prader–Willi syndrome. Psychol Med. 2008;38(10):1505–14.PubMedCrossRef Soni S, Whittington J, Holland AJ, Webb T, Maina EN, Boer H, et al. The phenomenology and diagnosis of psychiatric illness in people with Prader–Willi syndrome. Psychol Med. 2008;38(10):1505–14.PubMedCrossRef
29.
go back to reference Lo ST, Collin PJL, Hokken-Koelega ACS. Psychiatric disorders in children with Prader–Willi syndrome-results of a 2-year longitudinal study. Am J Med Genet A. 2015;167(5):983–91.CrossRef Lo ST, Collin PJL, Hokken-Koelega ACS. Psychiatric disorders in children with Prader–Willi syndrome-results of a 2-year longitudinal study. Am J Med Genet A. 2015;167(5):983–91.CrossRef
30.
go back to reference Feighan SM, Hughes M, Maunder K, Roche E, Gallagher L. A profile of mental health and behaviour in Prader–Willi syndrome. J Intellect Disabil Res. 2020;64(2):158–69.PubMedCrossRef Feighan SM, Hughes M, Maunder K, Roche E, Gallagher L. A profile of mental health and behaviour in Prader–Willi syndrome. J Intellect Disabil Res. 2020;64(2):158–69.PubMedCrossRef
31.
go back to reference Montes AS, Osann KE, Gold JA, Tamura RN, Driscoll DJ, Butler MG, et al. Genetic subtype-phenotype analysis of growth hormone treatment on psychiatric behavior in Prader–Willi syndrome. Genes (Basel). 2020;11(11):1–11.CrossRef Montes AS, Osann KE, Gold JA, Tamura RN, Driscoll DJ, Butler MG, et al. Genetic subtype-phenotype analysis of growth hormone treatment on psychiatric behavior in Prader–Willi syndrome. Genes (Basel). 2020;11(11):1–11.CrossRef
32.
go back to reference Verhoeven WMA, Curfs LMG, Tuinier S. Prader–Willi syndrome and atypical psychoses. Int Rev Neurobiol. 2002;17:171S-171S. Verhoeven WMA, Curfs LMG, Tuinier S. Prader–Willi syndrome and atypical psychoses. Int Rev Neurobiol. 2002;17:171S-171S.
33.
34.
go back to reference Verhoeven WMA, de Vries BBA, Duffels SJH, Egger JIM, Noordam C, Tuinier S. Klinefelter’s syndrome and Prader–Willi syndrome: a rare combination. Psychopathology. 2007;40(5):356–60.PubMedCrossRef Verhoeven WMA, de Vries BBA, Duffels SJH, Egger JIM, Noordam C, Tuinier S. Klinefelter’s syndrome and Prader–Willi syndrome: a rare combination. Psychopathology. 2007;40(5):356–60.PubMedCrossRef
35.
go back to reference Verhoeven WMA, Curfs LM, Tuinier S. Prader–Willi syndrome and cycloid psychoses. J Intell Disabil Res. 1998;42(Pt 6):455–62. Verhoeven WMA, Curfs LM, Tuinier S. Prader–Willi syndrome and cycloid psychoses. J Intell Disabil Res. 1998;42(Pt 6):455–62.
36.
go back to reference Verhoeven W, Egger J, Tuinier S. Thoughts on the behavioural phenotypes in Prader–Willi syndrome and velo-cardio-facial syndrome: a novel approach. Acta Neuropsychiatrica. 2007;19(4):244–50.PubMedCrossRef Verhoeven W, Egger J, Tuinier S. Thoughts on the behavioural phenotypes in Prader–Willi syndrome and velo-cardio-facial syndrome: a novel approach. Acta Neuropsychiatrica. 2007;19(4):244–50.PubMedCrossRef
37.
go back to reference Singh D, Sasson A, Rusciano V, Wakimoto Y, Pinkhasov A, Angulo M. Cycloid psychosis comorbid with Prader–Willi syndrome: a case series. Am J Med Genet A. 2019;7:34. Singh D, Sasson A, Rusciano V, Wakimoto Y, Pinkhasov A, Angulo M. Cycloid psychosis comorbid with Prader–Willi syndrome: a case series. Am J Med Genet A. 2019;7:34.
38.
go back to reference Briegel W. Clinical usefulness of aripiprazole treatment in a girl with Prader–Willi syndrome and psychosis. Clin Psychopharmacol Neurosci. 2018;16:497.PubMedPubMedCentralCrossRef Briegel W. Clinical usefulness of aripiprazole treatment in a girl with Prader–Willi syndrome and psychosis. Clin Psychopharmacol Neurosci. 2018;16:497.PubMedPubMedCentralCrossRef
40.
go back to reference Poser HM, Trutia AE, Report C. Treatment of a Prader–Willi patient with recurrent catatonia. Case Rep. 2015;2015:13. Poser HM, Trutia AE, Report C. Treatment of a Prader–Willi patient with recurrent catatonia. Case Rep. 2015;2015:13.
41.
go back to reference Sinnema M, Boer H, Collin P, Maaskant MA, van Roozendaal KEP, Schrander-Stumpel CTRM, et al. Psychiatric illness in a cohort of adults with Prader–Willi syndrome. Res Dev Disabil. 2011;32(5):1729–35.PubMedCrossRef Sinnema M, Boer H, Collin P, Maaskant MA, van Roozendaal KEP, Schrander-Stumpel CTRM, et al. Psychiatric illness in a cohort of adults with Prader–Willi syndrome. Res Dev Disabil. 2011;32(5):1729–35.PubMedCrossRef
42.
go back to reference Chiou P-N, Tsai L-P. Psychopharmacological treatment of Prader–Willi syndrome. Tzu Chi Med J. 2010;22(1):43–6.CrossRef Chiou P-N, Tsai L-P. Psychopharmacological treatment of Prader–Willi syndrome. Tzu Chi Med J. 2010;22(1):43–6.CrossRef
43.
go back to reference Hergüner S, Mukaddes NM. Psychosis associated with fluoxetine in Prader–Willi syndrome. J Am Acad Child Adolesc Psychiatry. 2007;46(8):944–5.PubMedCrossRef Hergüner S, Mukaddes NM. Psychosis associated with fluoxetine in Prader–Willi syndrome. J Am Acad Child Adolesc Psychiatry. 2007;46(8):944–5.PubMedCrossRef
44.
go back to reference Vogels A, De Hert M, Descheemaeker MJ, Govers V, Devriendt K, Legius E, et al. Psychotic disorders in Prader–Willi syndrome. Am J Med Genet A. 2004;127A(3):238–43.PubMedCrossRef Vogels A, De Hert M, Descheemaeker MJ, Govers V, Devriendt K, Legius E, et al. Psychotic disorders in Prader–Willi syndrome. Am J Med Genet A. 2004;127A(3):238–43.PubMedCrossRef
45.
go back to reference Watanabe H, Ohmori O, Abe K. Recurrent brief depression in Prader–Willi syndrome: a case report. Psychiatr Genet. 1997;7(1):12.CrossRef Watanabe H, Ohmori O, Abe K. Recurrent brief depression in Prader–Willi syndrome: a case report. Psychiatr Genet. 1997;7(1):12.CrossRef
46.
go back to reference Bhate MS, Robertson PE, Davison EV, Brummitt JA. Prader Willi syndrome with hypothyroidism. J Ment Defic Res. 1989;33(Pt 3):235–44.PubMed Bhate MS, Robertson PE, Davison EV, Brummitt JA. Prader Willi syndrome with hypothyroidism. J Ment Defic Res. 1989;33(Pt 3):235–44.PubMed
48.
go back to reference Zwiebel S, Rayapati AO, de Leon J. Catatonia following abrupt cessation of oxcarbazepine in a patient with Prader–Willi syndrome. Psychosomatics. 2019;60(3):311–5.PubMedCrossRef Zwiebel S, Rayapati AO, de Leon J. Catatonia following abrupt cessation of oxcarbazepine in a patient with Prader–Willi syndrome. Psychosomatics. 2019;60(3):311–5.PubMedCrossRef
49.
go back to reference Jacob R, Chowdhury A, Kamath S, Ganesan J. Psychiatric comorbidity in Prader–Willi syndrome a case series. German J Psychiatry. 2009;8:24. Jacob R, Chowdhury A, Kamath S, Ganesan J. Psychiatric comorbidity in Prader–Willi syndrome a case series. German J Psychiatry. 2009;8:24.
50.
go back to reference Takhar J, Malla AK. Clozapine therapy for psychosis and Parkinsonism in a phenotypical case of Prader–Willi syndrome. Can J Clin Pharmacol. 1997;4(2):79–81. Takhar J, Malla AK. Clozapine therapy for psychosis and Parkinsonism in a phenotypical case of Prader–Willi syndrome. Can J Clin Pharmacol. 1997;4(2):79–81.
51.
go back to reference Tyndall P, Fitzpatrick C. Psychotic episode in an adolescent with Prader–Willi syndrome: a case report. Genet Couns. 1997;8(3):275. Tyndall P, Fitzpatrick C. Psychotic episode in an adolescent with Prader–Willi syndrome: a case report. Genet Couns. 1997;8(3):275.
52.
go back to reference Bartolucci G, Younger J. Tentative classification of neuropsychiatric disturbances in Parader-Willi syndrome. J Intell Disabil Res. 1994;38(6):621–9.CrossRef Bartolucci G, Younger J. Tentative classification of neuropsychiatric disturbances in Parader-Willi syndrome. J Intell Disabil Res. 1994;38(6):621–9.CrossRef
54.
go back to reference Larson FV, Whittington J, Webb T, Holland AJ. A longitudinal follow-up study of people with Prader–Willi syndrome with psychosis and those at increased risk of developing psychosis due to genetic subtype. Psychol Med. 2014;44(11):2431–5.PubMedCrossRef Larson FV, Whittington J, Webb T, Holland AJ. A longitudinal follow-up study of people with Prader–Willi syndrome with psychosis and those at increased risk of developing psychosis due to genetic subtype. Psychol Med. 2014;44(11):2431–5.PubMedCrossRef
55.
go back to reference Webb T, Maina EN, Soni S, Whittington J, Boer H, Clarke D, et al. In search of the psychosis gene in people with Prader–Willi syndrome. Am J Med Genet A. 2008;146A(7):843–53.PubMedCrossRef Webb T, Maina EN, Soni S, Whittington J, Boer H, Clarke D, et al. In search of the psychosis gene in people with Prader–Willi syndrome. Am J Med Genet A. 2008;146A(7):843–53.PubMedCrossRef
56.
go back to reference Soni S, Whittington J, Holland AJ, Webb T, Maina E, Boer H, et al. The course and outcome of psychiatric illness in people with Prader–Willi syndrome: implications for management and treatment. J Intellect Disabil Res. 2007;51(Pt 1):32–42.PubMedCrossRef Soni S, Whittington J, Holland AJ, Webb T, Maina E, Boer H, et al. The course and outcome of psychiatric illness in people with Prader–Willi syndrome: implications for management and treatment. J Intellect Disabil Res. 2007;51(Pt 1):32–42.PubMedCrossRef
58.
go back to reference Kocsis A, Gajwani R, Gross J, Gumley AI, Lawrie SM, Schwannauer M, et al. Altered autonomic function in individuals at clinical high risk for psychosis. Front Psychiatry. 2020;11:580503.PubMedPubMedCentralCrossRef Kocsis A, Gajwani R, Gross J, Gumley AI, Lawrie SM, Schwannauer M, et al. Altered autonomic function in individuals at clinical high risk for psychosis. Front Psychiatry. 2020;11:580503.PubMedPubMedCentralCrossRef
59.
go back to reference Frances AJ, Kahn DA, Carpenter D, Docherty JP, Donovan SL. The expert consensus guidelines for treating depression in bipolar disorder. J Clin Psychiatry. 1998;59(4):73–9.PubMed Frances AJ, Kahn DA, Carpenter D, Docherty JP, Donovan SL. The expert consensus guidelines for treating depression in bipolar disorder. J Clin Psychiatry. 1998;59(4):73–9.PubMed
60.
go back to reference Krishnadas R, Cooper SA, Nicol A, Pimlott S, Soni S, Holland AJ, et al. Brain-stem serotonin transporter availability in maternal uniparental disomy and deletion Prader–Willi syndrome. Br J Psychiatry. 2018;212(1):57–8.PubMedCrossRef Krishnadas R, Cooper SA, Nicol A, Pimlott S, Soni S, Holland AJ, et al. Brain-stem serotonin transporter availability in maternal uniparental disomy and deletion Prader–Willi syndrome. Br J Psychiatry. 2018;212(1):57–8.PubMedCrossRef
61.
go back to reference Äberg ND, Carlsson B, Rosengren L, Oscarsson J, Isaksson OGP, Rönnbäck L, et al. Growth hormone increases connexin-43 expression in the cerebral cortex and hypothalamus. Endocrinology. 2000;141(10):3879–86.PubMedCrossRef Äberg ND, Carlsson B, Rosengren L, Oscarsson J, Isaksson OGP, Rönnbäck L, et al. Growth hormone increases connexin-43 expression in the cerebral cortex and hypothalamus. Endocrinology. 2000;141(10):3879–86.PubMedCrossRef
62.
go back to reference Bonnot O, Cohen D, Thuilleaux D, Consoli A, Cabal S, Tauber M. Psychotropic treatments in Prader–Willi syndrome: a critical review of published literature. Eur J Pediatr. 2016;175(1):9–18.PubMedCrossRef Bonnot O, Cohen D, Thuilleaux D, Consoli A, Cabal S, Tauber M. Psychotropic treatments in Prader–Willi syndrome: a critical review of published literature. Eur J Pediatr. 2016;175(1):9–18.PubMedCrossRef
64.
go back to reference Perris C, Brockington IF, Struwe D, Janson B. Biological psychiatry. 1981. Perris C, Brockington IF, Struwe D, Janson B. Biological psychiatry. 1981.
Metadata
Title
Psychotic illness in people with Prader–Willi syndrome: a systematic review of clinical presentation, course and phenomenology
Authors
Lucie C. S. Aman
Suzannah D. Lester
Anthony J. Holland
Paul C. Fletcher
Publication date
01-12-2024
Publisher
BioMed Central
Keywords
Confusion
Anxiety
Published in
Orphanet Journal of Rare Diseases / Issue 1/2024
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-024-03026-y

Other articles of this Issue 1/2024

Orphanet Journal of Rare Diseases 1/2024 Go to the issue